Scott L M LM - OmicsDI

Show results for

Unknown (514)
Transcriptomics (20)
Genomics (17)
Proteomics (10)
Metabolomics (4)

Organisms

Homo sapiens (30)
Drosophila melanogaster (5)
Mus musculus (5)
Aspergillus niger (1)
Arabidopsis lyrata (1)
Escherichia coli (1)
Saccharomyces cerevisiae (1)
Arabidopsis thaliana (1)
Plasmodium falciparum 3D7 (1)

Repository

biostudies-arrayexpress (23)
EGA (14)
pride (8)
MetaboLights (3)
MassIVE (2)
GNPS (1)

Tissue

Blood (2)
T cell (2)
Blood cell (1)
Cell culture (1)

Disease

Malaria (1)
Neurodevelopmental delay (1)

Technology Type

Mass Spectrometry (8)
Bottom-up proteomics (4)
Mass spectrometry (2)
Data-dependent acquisition (2)
Shotgun proteomics (2)
Illumina HiSeq 2000, Illumina Infinium HumanMethylation450 BeadChip, Affymetrix expression array, ILLUMINA (1)
Illumina HiSeq 2500, Illumina MiSeq, NextSeq 500, Illumina HiSeq 2000 (1)
Mass spectrometry assay (1)
NMR spectroscopy assay (1)
Affinity proteomics (1)
All-ion fragmentation (1)
Data-independent acquisition (1)
DiaPASEF (1)

Instrument Platform

Agilent 7890A GC coupled to a 5975C inert XL MSD (2)
Q Exactive Plus (2)
Q Exactive (2)
Synapt G2 MS (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - hilic (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2010 (9)
2025 (6)
2014 (3)
2013 (3)
2012 (3)
2011 (2)
2020 (2)
2023 (2)
2024 (2)
2015 (1)
2009 (1)
2008 (1)
2021 (1)
2026 (1)

CHEBI ID

CHEBI:10072 (2)
CHEBI:10362 (2)
CHEBI:132948 (2)
CHEBI:133032 (2)
CHEBI:133119 (2)
CHEBI:133176 (2)
CHEBI:133181 (2)
CHEBI:133185 (2)
CHEBI:133460 (2)
CHEBI:133530 (2)
CHEBI:133532 (2)
CHEBI:134538 (2)
CHEBI:138529 (2)
CHEBI:145970 (2)
CHEBI:15354 (2)
CHEBI:15428 (2)
CHEBI:15676 (2)
CHEBI:15689 (2)
CHEBI:15724 (2)
CHEBI:15859 (2)
CHEBI:15891 (2)
CHEBI:15999 (2)
CHEBI:16020 (2)
CHEBI:1606 (2)
CHEBI:16113 (2)
CHEBI:16175 (2)
CHEBI:16199 (2)
CHEBI:16244 (2)
CHEBI:16344 (2)
CHEBI:16359 (2)

Metabolite Name

1-methyl-4-imidazoleacetate (2)
1-methylnicotinamide (2)
2'-O-methyluridine (2)
2'-deoxyuridine (2)
2,3-dihydroxyisovalerate (2)
2-hydroxy-3-methylvalerate (2)
2-hydroxyacetaminophen sulfate* (2)
2-hydroxyadipate (2)
2-hydroxybutyrate/2-hydroxyisobutyrate (2)
2-hydroxyglutarate (2)
2-hydroxynervonate* (2)
2-hydroxypalmitate (2)
2-hydroxystearate (2)
2-methoxyacetaminophen sulfate* (2)
2-oxoarginine* (2)
2-piperidinone (2)
21-hydroxypregnenolone disulfate (2)
3-(3-amino-3-carboxypropyl)uridine* (2)
3-(4-hydroxyphenyl)lactate (2)
3-(cystein-S-yl)acetaminophen* (2)
3-amino-2-piperidone (2)
3-aminoisobutyrate (2)
3-hydroxy-3-methylglutarate (2)
3-hydroxyhippurate (2)
3-hydroxysebacate (2)
3-indoxyl sulfate (2)
3-methyl-2-oxovalerate (2)
3-methylglutarate/2-methylglutarate (2)
3-methylxanthine (2)
3-ureidopropionate (2)

Study type

Transcription profiling by array (12)
ChIP-chip by tiling array (6)
ChIP-seq (2)
Other (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of non coding RNA (1)

Release Date

2022 (65)
2021 (57)
2023 (48)
2024 (38)
2015 (35)
2025 (33)
2017 (33)
2018 (30)
2014 (29)
2019 (29)
2016 (28)
2020 (25)
2013 (23)
2010 (18)
2012 (14)
2011 (14)
2008 (8)
2009 (4)
2026 (4)
2007 (1)
2006 (1)

Lab affiliation

95 Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, 31077, France (1)
Centre for Proteome Research, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Crown Street, Liverpool, L69 7ZB, U.K. (1)
Department of Biochemistry, University of Cambridge, United Kingdom (1)
Department of Biological Sciences, University of Alberta, Edmonton, AB, T6G2T2, Canada; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, T6G2T2, Canada; Women and Children's Health Research Institute, Edmonton, AB, T6G2T2 (1)
Head of Proteomics, Beatson Institute for Cancer Research (1)
Head, Inflammation Division Professor and NHMRC Leadership Fellow Walter and Eliza Hall Institute of Medical Research 1G Royal Parade Parkville, VIC 3052, Australia (1)
Head, Inflammation Division Professor and NHMRC Leadership Fellow Walter and Eliza Hall Institute of Medical Research 1G Royal Parade Parkville, VIC 3052, Australia (lab head) (1)
Universitätsmedizin Greifswald Interfakultäres Institut für Genetik und Funktionelle Genomforschung Abteilung für Funktionelle Genomforschung Felix-Hausdorff-Straße 8 17487 Greifswald (1)

Previous page
1 / 57
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 57
Next page

Sort by:

Relevance

Page size

A Murine Model of Maternal Micronutrient Deficiencies and Gut Inflammatory Host-microbe Interactions in the Offspring.

BACKGROUND & AIMS: Micronutrient deficiency (MND) (ie, lack of vitamins and minerals) during pregnancy is a major public health concern. Historically, studies have considered micronutrients in isolation; however, MNDs rarely occur alone. The impact of co-occurring MNDs on pu...

2024-10-18 | MTBLS3476 | MetaboLights

Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

Fecal microbiota transplantation (FMT) represents a potential strategy to overcome resistance to immune checkpoint inhibitors in patients with refractory melanoma; however, the role of FMT in first-line treatment settings has not been evaluated. We conducted a multicenter phase I trial combining ...

2025-02-27 | MTBLS711 | MetaboLights

Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced Cancer.

Not available

S-EPMC5321045 | biostudies-literature

Hes6 expression is controlled by c-Myc and the AR to promote E2F1 activity and poor outcome in castrate-resistant prostate cancer (xenografts)

Hes6 is a transcription co-factor that is associated with stem cell characteristics in neural tissue, but its role in cancer remains uncertain. Here we show that Hes6 is controlled by c-Myc and the AR and can drive castration resistance in xenografts of the androgen-dependent LNCaP prostate cancer c...

ORGANISM(S): Homo sapiens

2014-04-17 | E-GEOD-36433 | biostudies-arrayexpress

ChIP-seq of chromatin modifications and factors associated with transcriptionally active regions of the genome in mES cells

Post-translational modification of histones are coupled to transcription where certain modifications are indicative of an active or inactive region of the genome. Additionally, protein complexes can regulate the placement of nucleosomes across the genome and this influences the ability of DNA-bindi...

ORGANISM(S): Mus musculus

2012-03-17 | E-GEOD-36561 | biostudies-arrayexpress

Replenishing Age-Related Decline of IRAK-M Expression in Retinal Pigment Epithelium Attenuates Outer Retinal Degeneration.

Not available

S-EPMC10557650 | biostudies-literature

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.

Not available

S-EPMC4872317 | biostudies-literature

indentification of PA modified proteins

Enrichment of polysialylated proteins from NK92 cells

ORGANISM(S): Homo sapiens (Human)

2024-02-21 | PXD040100 | Pride